1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Cardiac Markers Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Cardiac Markers Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Cardiac Markers Market Regional Analysis
6.2 North America Cardiac Markers Market Revenue 2021-2031 (US$ Billion)
6.3 North America Cardiac Markers Market Forecast Analysis
7. North America Cardiac Markers Market Analysis – by Product Type
7.1 Reagents and Kits
- 7.1.1 Overview
- 7.1.2 Reagents and Kits: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
7.2 Analyzers
- 7.2.1 Overview
- 7.2.2 Analyzers: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
8. North America Cardiac Markers Market Analysis – by Biomarker Type
8.1 Troponin
- 8.1.1 Overview
- 8.1.2 Troponin: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
8.2 Creatine Kinase-MB
- 8.2.1 Overview
- 8.2.2 Creatine Kinase-MB: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
8.3 Myoglobin
- 8.3.1 Overview
- 8.3.2 Myoglobin: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
8.4 B-Type Natriuretic Peptide
- 8.4.1 Overview
- 8.4.2 B-Type Natriuretic Peptide: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
9. North America Cardiac Markers Market Analysis – by Indication
9.1 Congestive Heart Failure
- 9.1.1 Overview
- 9.1.2 Congestive Heart Failure: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
9.2 Myocradial Infraction
- 9.2.1 Overview
- 9.2.2 Myocradial Infraction: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
9.3 Acute Coronary Syndrome
- 9.3.1 Overview
- 9.3.2 Acute Coronary Syndrome: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
10. North America Cardiac Markers Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
10.2 Diagnostic Laboratories
- 10.2.1 Overview
- 10.2.2 Diagnostic Laboratories: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
10.3 Point-of-Care Testing Facilities
- 10.3.1 Overview
- 10.3.2 Point-of-Care Testing Facilities: North America Cardiac Markers Market – Revenue and Forecast, 2021-2031 (US$ Billion)
11. North America Cardiac Markers Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Cardiac Markers Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 North America Cardiac Markers Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)
- 11.2.1.1.1 US: North America Cardiac Markers Market Breakdown, by Product Type
- 11.2.1.1.2 US: North America Cardiac Markers Market Breakdown, by Biomarker Type
- 11.2.1.1.3 US: North America Cardiac Markers Market Breakdown, by Indication
- 11.2.1.1.4 US: North America Cardiac Markers Market Breakdown, by End User
- 11.2.1.2 Canada:
North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)
- 11.2.1.2.1 Canada: North America Cardiac Markers Market Breakdown, by Product Type
- 11.2.1.2.2 Canada: North America Cardiac Markers Market Breakdown, by Biomarker Type
- 11.2.1.2.3 Canada: North America Cardiac Markers Market Breakdown, by Indication
- 11.2.1.2.4 Canada: North America Cardiac Markers Market Breakdown, by End User
- 11.2.1.3 Mexico :
North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)
- 11.2.1.3.1 Mexico : North America Cardiac Markers Market Breakdown, by Product Type
- 11.2.1.3.2 Mexico : North America Cardiac Markers Market Breakdown, by Biomarker Type
- 11.2.1.3.3 Mexico : North America Cardiac Markers Market Breakdown, by Indication
- 11.2.1.3.4 Mexico : North America Cardiac Markers Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Beckman Coulter Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Creative Diagnostics
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Bio-Rad Laboratories Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Diazyme Laboratories Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 bioMerieux SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 HyTest Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 QuidelOrtho Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Thermo Fisher Scientific Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 F. Hoffmann-La Roche Ltd
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For North America Cardiac Markers Market
